Search
for
Sort by
Research 511–540 of 1000+
- Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
- Hearing threshold abnormalities in patients with alopecia areata
- Expression of Long Noncoding RNA, HOTAIR, and MicroRNA-205 and Their Relation to Transforming Growth Factor β1 in Patients with Alopecia Areata
- 33766 Efficacy of baricitinib in patients with various degrees of alopecia areata severity: Results from BRAVE-AA1 and BRAVE-AA2
- Histone deacetylase 1 in patients with alopecia areata and acne vulgaris: An epigenetic alteration
- Real-world assessment of ritlecitinib in patients with severe alopecia areata: a 24-week multicentre retrospective study
- Alopecia areata in Black African patients: epidemiological, clinical, and therapeutic aspects
- Serum level of osteopontin in patients with alopecia areata and its correlation with ocular changes
- Herb lotions to regrow hair in patients with intractable alopecia areata
- 723 - Efficacy of ritlecitinib in patients with alopecia areata by extent of hair loss at baseline: post hoc analysis of the phase 3 long-term ALLEGRO-LT study
- Support Group Participation Among Patients With Alopecia Areata
- Adjuvant Scalp Rolling for Patients With Refractory Alopecia Areata
- Trajectories For Scalp Hair Regrowth In Patients With Severe Alopecia Areata Treated With Baricitinib
- Prevalence and Risk Factors Associated with the Occurrence of Autoimmune Diseases in Patients with Alopecia Areata
- Response to “Vitamin D deficiency in patients with alopecia areata: A systematic review and meta-analysis” and an investigation of vitamin D in pediatric patients
- Serum levels of interleukin-1 (IL-1α, IL-1β) in patients with alopecia areata
- Clinical Characteristics, Treatment Patterns, and Outcomes of Chinese Patients With Alopecia Areata: A Retrospective Observational Study
- Adis Summary of Research: Improvement in measures of quality of life and symptoms of anxiety and depression in patients with severe alopecia areata achieving sustained scalp hair regrowth with baricitinib
- Changes in immune status parameters in patients with alopecia areata undergoing combined therapy
- Associated comorbidities in pediatric patients with alopecia areata
- Hematological ratios in pediatric patients with alopecia areata based on a nationwide retrospective cohort study
- Table 1_Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata.docx
- The relationship between psychological distress and neurotrophins in patients with alopecia areata: A crosssectional study
- Biologics and small molecules for patients with concomitant alopecia areata and vitiligo: A review
- Characterizing Lipid Changes and Use of Lipid-Lowering Medications in Patients With Alopecia Areata Treated With Baricitinib: Integrated Results From the BRAVE-AA1 and -AA2 Clinical Trials
- 52898 Among scalp non-responder patients with eyebrow/eyelash regrowth in the first year, continued treatment with baricitinib resulted in meaningful scalp responses for patients with severe alopecia areata
- Baricitinib Withdrawal and Retreatment in Patients With Severe Alopecia Areata
- Assessment of Quality of Life among Patients with Alopecia Areata
- Elevation of circulating DNAs of disease-associated cytokines in serum cell-free DNA from patients with alopecia areata
- VITAMIN D DEFICIENCY IN PATIENTS WITH ALOPECIA AERATA, AND RESPONSIVENESS TO VITAMIN D ANALOGUES: A SYSTEMATIC REVIEW